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ABSTRACT
Anxiety disorders in childhood and adolescence are
extremely common and are often associated with lifelong
psychiatric disturbance. Consistent with DSM-5 and the
extant literature, this review concerns the assessment
and treatment of speciﬁc phobias, separation anxiety
disorder, generalised anxiety disorder, social anxiety
disorder, panic disorder and agoraphobia. Evidence-
based psychological treatments (cognitive behaviour
therapy; CBT) for these disorders have been developed
and investigated, and in recent years promising low-
intensity versions of CBT interventions have been
proposed that offer a means to increase access to
evidence-based treatments. There is some evidence of
effectiveness of pharmacological treatments for anxiety
disorders in children and young people, however, routine
prescription is not recommended due to concerns about
potential harm.
INTRODUCTION
Anxiety disorders are among the most common
psychiatric conditions in young people, with com-
munity studies indicating a period prevalence
between 9% and 32% during childhood and ado-
lescence.1 They typically have an adverse impact on
educational achievement, family life and leisure
activities2 3; and they often co-occur with other
anxiety disorders, depression and behavioural dis-
orders.4 Anxiety disorders in young people are
associated with increased rates of anxiety and
depression in early adulthood, as well as with a
number of other adverse mental health and life
course outcomes.5 6 Indeed, for the majority of
adults with anxiety disorders and depression the
onset of psychological difﬁculties was in childhood
or adolescence, with anxiety disorders being the
most common prior diagnosis.7 Despite the signiﬁ-
cant public health burden associated with anxiety
disorders in children and young people, they com-
monly remain untreated.8 Collectively these consid-
erations highlight the importance of early access to
effective identiﬁcation and treatment.
Classiﬁcation of anxiety disorders among
children and adolescents
There have been some recent changes to the classiﬁ-
cation of anxiety disorders. Consistent with the pre-
vious version of the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV9), DSM-510
includes the following anxiety disorders: speciﬁc
phobia, generalised anxiety disorder, social anxiety
disorder (formerly social phobia), panic disorder and
agoraphobia. Key changes in DSM-5 include: (i)
agoraphobia has been classiﬁed as a stand-alone diag-
nosis (ie, no longer linked to the presence or absence
of panic disorder), (ii) separation anxiety disorder
and selective mutism have been re-classiﬁed as
anxiety disorders (rather than in a section for ‘disor-
ders usually ﬁrst diagnosed in infancy, childhood or
adolescence’) and (iii) obsessive-compulsive disorder,
post-traumatic stress disorder and acute stress dis-
order are, respectively, grouped under obsessive-
compulsive and related disorders, and trauma-related
and stressor-related disorders (ie, no longer included
within the anxiety disorders category).i While core
features of each anxiety disorder are broadly consist-
ent with DSM-IV, in order to minimise the over-
diagnosis of transient fears for agoraphobia, speciﬁc
phobia and social anxiety disorder, those under the
age of 18 are now required to have had symptoms
for at least 6 months.
ASSESSMENT
Young people with anxiety disorders are unlikely to
present for help independently, with parents com-
monly raising concerns to general practitioners.
The challenge in assessing for the presence of
anxiety disorders is distinguishing pathology from
‘normal’ developmentally appropriate fears and
worries. As anxiety disorders represent an extreme
presentation of normal events, this distinction is
essentially made on the basis of the severity and
persistence of symptoms and the degree of asso-
ciated impairment. Structured interview schedules
used for assessing the presence of anxiety disorders
typically establish whether a child meets symptom
criteria for a speciﬁc anxiety diagnosis, as well as
the degree to which these symptoms interfere with
functioning. The most widely used diagnostic
schedule is the Anxiety Disorders Interview
Schedule for children and parents (ADIS-C/P18)
iConsistent with the reclassiﬁcation in DSM-5, we have
not included OCD and PTSD in this review. In any event,
treatment research for these disorders has, in the main,
involved the assessment of disorder-speciﬁc treatments11
and clinical recommendations for these two conditions
are, therefore, somewhat different from those for
disorders under consideration in this paper.12 13 We have
also not included selective mutism although this has now
been classiﬁed as an anxiety disorder within DSM-5.
There has been little systematic evaluation of treatments
beyond uncontrolled case studies and single-participant
experiments.14 Two small controlled trials using
ﬂuoxetine15 16 indicate that it may be of some beneﬁt and
more recently, a small randomized controlled pilot study
has provided preliminary evidence for the effectiveness of
behaviour therapy.17 Consequently as treatment design
and evaluation for selective mutism is at such an early
stage, and because children with selective mutism have
not typically been included in treatments for general
anxiety disorders, it is not included within the body of
this review.
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which follows DSM-IV criteria. Questionnaire measures with
normative data also provide a useful indication of whether
symptoms are present at a clinical level. While there are no brief
screening measures for use with children and young people,
parent and child report measures such as the Revised Children’s
Anxiety and Depression Scale (RCADS19) and the Spence
Children’s Anxiety Scale (SCAS20) contain scales that broadly
align with diagnostic categories. These tools are valuable in
helping to identify clinical levels of anxiety among young
people (as diagnostic cut-offs are available) and they can be
useful in monitoring progress through treatment. Although
National Institute of Health and Care Excellence (NICE) guide-
lines relating to anxiety disorders principally relate to adults,
the recent NICE guideline for the assessment and treatment of
social anxiety disorder21 highlights a number of considerations
for assessment with young people which can be applied across
the anxiety disorders. It is noted, in particular, that once poten-
tial concerns relating to anxiety have been identiﬁed in a young
person, a comprehensive assessment should be conducted by an
appropriate healthcare professional. This should include an
opportunity for interviewing the young person on their own;
and it should also involve interviewing a parent, carer or other
adult who knows the child well and can report on current and
past behaviour. Since there is a high level of comorbidity in
young people with anxiety disorders, it is essential to assess for
possible co-existing mental health problems, neurodevelopmen-
tal conditions, drug and alcohol misuse, and speech and lan-
guage problems.
MANAGEMENT
The most commonly evaluated treatments for anxiety disorders
in children and adolescence are psychological approaches, espe-
cially cognitive behaviour therapy (CBT). One of the ﬁrst man-
ualised CBT programmes for the treatment of anxiety disorders
in young people was Kendall’s ‘Coping Cat’.22 This includes
components concerned with psycho-education, identiﬁcation
and modiﬁcation of negative automatic thoughts, exposure to
feared stimuli, problem solving, and training in coping skills.
Most programmes subsequently developed are heavily inﬂu-
enced by ‘Coping Cat’.
The great majority of young people with anxiety disorders do
not access clinical services.23 This is likely to be the result of a
lack of awareness and knowledge, lack of appropriate local ser-
vices, long waiting lists for treatment, competing family time
commitments and a paucity of trained professionals. In line
with guidance for increasing access to treatment in adult popula-
tions,24 recent therapeutic innovations have focused on brief or
low-intensity versions of CBT that can be delivered by non-
specialists, with the ultimate aim of delivering treatment within
a stepped-care framework. The logic here is to deliver brief,
relatively simple, ﬁrst-line treatments routinely to service users
with a relatively good prognosis, reserving more intensive treat-
ments for those who do not respond to the ﬁrst-line treatment
and those whose prognostic proﬁle indicates that they require
more input.25
Low-intensity interventions for anxiety disorders in
childhood and adolescence
Two low-intensity approaches have been subjected to systematic
evaluation: (i) brief treatments in which parents are guided to
work through a book that instructs them on how to help their
child overcome their difﬁculties with anxiety (‘bibliotherapy’)
and (ii) treatments delivered via computerised platforms
(‘e-therapies’).
Bibliotherapy
Promising evidence is emerging of impressive clinical gains
using low-intensity CBT for child anxiety delivered by parents.
Notably, in an Australian study, the simple provision of a work-
book for parents was associated with recovery in 26% of
anxious children aged 6–12 years, compared to 7% who
received no treatment.26 The addition of therapist support,
however, has been found to be associated with substantially
higher recovery rates. Lyneham and Rapee,27 for example, in a
study of the treatment of childhood anxiety in a rural Australian
population, supplemented a workbook for parents with nine
scheduled weekly phone calls or emails. Almost 90% of children
no longer met diagnostic criteria for their primary anxiety dis-
order following treatment, and gains were maintained at a
12-month follow-up. Notably, in a further Australian study of
the treatment of anxious children, no difference in child
outcome was found between bibliotherapy delivered via parents
(supported by a 2-h group plus regular phone calls) compared
to outcome following twelve 60–90 min sessions of CBT deliv-
ered with parents and children.28 A similar approach has
recently been applied with a referred population from a UK
National Health Service setting.29 A sample of anxious children
(of non-anxious mothers) received an intervention where
parents were given a CBT manual30 and 5 h 20 min contact
(face-to-face sessions and telephone reviews) with a therapist to
help them apply the manual’s principles. Immediately following
the intervention 50% of children were free of their primary
diagnosis (double the rate in the waitlist control group), increas-
ing to over 70% at 6-month follow-up. Notably, in this study,
level of therapist experience was unrelated to child outcome,
suggesting that this low-intensity approach can be delivered
effectively by novice therapists. Together these studies suggest
that therapist guided bibliotherapy, delivered via parents, is an
effective and efﬁcient treatment for child anxiety.
E-therapies
Two computerised treatment programmes for childhood anxiety
disorders have been developed and systematically evaluated:
BRAVE for Children-Online31 and Camp-Cope-A-Lot: The
Coping Cat.32 Both programmes involve the child completing
10–12 computerised CBT sessions, with some additional ses-
sions for parents. Sessions are therapist-supported. In BRAVE
for Children-Online, the therapist provides weekly personalised
emails and one telephone call to help the child plan their expos-
ure hierarchy. In Camp-Cope-A-Lot, the therapist is present for
six sessions and assists in implementing exposure tasks. In
studies of both approaches computerised treatment was superior
to the waitlist and received high patient satisfaction ratings.
March et al31 found that 30% of the children who received
BRAVE for Children-Online were free of their primary diagnosis
immediately post-treatment; however, few children had com-
pleted all therapy sessions. By 6-month follow-up, when 62% of
children had completed all sessions, 75% of recruited partici-
pants were free of their primary diagnosis. Khanna and
Kendall32 found Camp-Cope-A-Lot to be as effective as
face-to-face CBT; 81% were free of their primary diagnosis at
post-treatment with progress maintained at 3-month follow-up.
Three computerised treatments designed speciﬁcally for
anxious adolescents have been evaluated: BRAVE for
Teenagers-Online,33 Cool Teens34 and Think, Feel Do.35 Spence
et al33 compared BRAVE for Teenagers-Online to individual,
clinic-based CBTand found no differences between groups post-
treatment and at follow-up assessments. By the 12-month
2 Creswell C, et al. Arch Dis Child 2014;0:1–5. doi:10.1136/archdischild-2013-303768
Review
 group.bmj.com on March 18, 2014 - Published by adc.bmj.comDownloaded from 
follow-up, 68% of those who received the online treatment
were free of their primary anxiety disorder diagnosis. In Cool
Teens, the adolescent undertakes 12 sessions via a CD-ROM,
with parent support and regular telephone calls from a therapist.
Wuthrich et al34 compared Cool Teens with a waitlist and found
similar end of treatment results to the Spence et al33; however,
in contrast to Spence, there was deterioration by the 3-month
follow-up. Finally, encouraging preliminary ﬁndings have been
obtained using the Think, Feel, Do programme in relation to
symptoms of social anxiety.35 Taken together, these studies
suggest that e-therapies may be a promising low-intensity
approach for the treatment of anxiety disorders in children and
adolescents.
High-intensity interventions for anxiety disorders in
childhood and adolescence
More intensive treatments for childhood anxiety, typically
involving 9–20 face-to-face CBT treatment sessions, have been
subjected to extensive evaluation. In a Cochrane review, James
et al36 identiﬁed 41 systematic evaluations of CBTwith children
and young people with anxiety disorders aged above four and
below 19 years of age. The odds ratio (OR) for remission across
these studies was 0.13 for CBT versus waiting list controls, with
CBT effective in over 59% of cases compared to 18.4% in con-
trols. Method of treatment delivery (ie, individually with the
child, in a group, or with parents/the family) was not systematic-
ally related to outcome. Notably, eight of these studies included
an active therapeutic comparison condition (eg, educational
support) and, collectively, these studies did not show superior
outcomes for those receiving CBT. While one could not, there-
fore, conclude from the current evidence base that CBT is the
most effective form of treatment, it is the only treatment with
an adequate evidence base to support its general application.
The majority of randomised controlled trials to evaluate CBT
for anxiety disorders in young people have included children
over 7 years of age. The extent to which CBT is applicable to
younger children has been debated. It has been questioned
whether young children have the cognitive capacities to beneﬁt
from the cognitive components of treatment; and it has been
noted that the modiﬁcation of young children’s behaviour is
heavily reliant on parental inﬂuences. Nevertheless, some posi-
tive ﬁndings have been reported with young children.
Hirshfeld-Becker et al37 demonstrated the effectiveness of a
parent and child programme for the treatment of 4–7-year-old
children with an anxiety disorder, as did Waters, Ford, Wharton
and Cobham38 with 4–8-year-old children. In the latter study
similar outcomes were found whether the treatment was deliv-
ered with parents and children or with parents alone. A group
CBT programme delivered solely to parents has also been
shown to be effective for 2–9-year-old children with anxiety
disorders.39
The studies described above have typically included children
with a range of anxiety disorders. This is partly driven by theor-
etical considerations, in that there are no well-validated
diagnosis-speciﬁc models of the maintenance of disorder in chil-
dren and young people; and partly for practical reasons, in that
there is such a high level of comorbidity between the anxiety
disorders.40 There has been some recent suggestion, however,
that disorder-speciﬁc treatments may be associated with better
outcomes for some disorders, especially social anxiety disorder.
Indeed, a number of recent reports have noted that children and
young people with social anxiety disorder do not make as sub-
stantial gains from generic treatment as those with other anxiety
disorders.41–43 Correspondingly, recent meta-analyses have
revealed better outcomes for young people with social anxiety
disorder following disorder-speciﬁc compared to generic treat-
ments.11 44 These ‘speciﬁc’ treatments have typically included
the addition to generic treatments of social skills training and
opportunities for peer interactions. There has been some inter-
est in speciﬁc treatments for other conditions, such as speciﬁc
phobias45 and separation anxiety disorder.46 For separation
anxiety disorder no clear advantage over generic treatments has
emerged to date.46 For speciﬁc phobias, direct comparisons
with generic treatments have not been conducted; however,
some evidence suggests that taking an especially focused
approach may allow for particularly rapid treatment. Thus, brief
exposure-based treatment has been found to be effective com-
pared to an active (education support) control, with 55% of
children being free of their speciﬁc phobia after a single treat-
ment session.45
Considerations for good practice in the delivery of
psychological interventions for children and young people
with anxiety disorders
The recent NICE guidelines for the assessment and treatment of
social anxiety disorder21 set out treatment principles for
working with children and young people that apply well across
the anxiety disorders. Speciﬁcally, it is noted that all interven-
tions should be delivered by competent practitioners who
receive regular, high-quality supervision that is informed by
routine monitoring of treatment progress from each treatment
session. The content of treatment should be based on relevant
evidence-based treatment manuals, and adherence to these
manuals should be monitored and evaluated in supervision, for
example, using video or audio recordings of treatment sessions.
Therapists should be aware of the potential impact of the child’s
home, school and wider social environment on the maintenance
and treatment of anxiety disorders, so should work with the
child or young person’s parents, teachers or peers, as appropri-
ate, to create an environment that supports the goals of
treatment.
Medication
There is some evidence that medication can be effective in treat-
ing anxiety in children and adolescents, at least in the short
term. A recent meta-analysis47 showed anxiolytic medication to
be associated with a signiﬁcantly greater clinical response than a
placebo drug (58.1% vs 31.5%). Selective serotonin reuptake
inhibitors (SSRIs) are regarded as the pharmacological treatment
of choice for anxiety disorders in children and adolescents
because of their effectiveness and safety proﬁle. It is important
to note that benzodiazepines have not been systematically evalu-
ated in children and adolescents and, in view of concerns about
dependency and side effects,48 their use is not recommended.21
The relative effectiveness of psychological and pharmaco-
logical treatments for anxiety disorders in children and young
people has been assessed in two trials. Beidel et al49 compared
SSRIs to CBT in the treatment of social anxiety disorder in chil-
dren and adolescents (7–17 years) and found CBT to be more
effective than ﬂuoxetine at the end of the treatment phase;
however, Walkup et al50 in a sample of children and young
people with a range of anxiety disorders, found no difference in
outcome immediately after treatment between those treated
with sertraline and those treated with CBT. Walkup and collea-
gues did, however, ﬁnd the combination of sertraline and CBT
to be more effective than either treatment alone. In the latter
study, by 24 weeks after the end of acute treatment (with
ongoing maintenance of sertraline or CBT booster sessions),
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there continued to be no signiﬁcant differences between CBT
and sertraline, although the advantage of the combined treat-
ment had attenuated somewhat.51
These recent ﬁndings suggest that CBT, sertraline and their
combination are all possible options for the treatment of child-
hood anxiety disorders. However, several important questions
concerning the use of anxiolytic medication in children remain
unanswered. Thus, it is unclear if there is an age below which
medication would be contraindicated; it is uncertain what the
duration of treatment should be; and, most notably, it is
unknown what the clinical consequences are of stopping a
course of medication.48 As a result of these uncertainties,
together with parental preference for psychological over
pharmacological interventions for their children,52 the NICE
guidelines for social anxiety disorder21 recommend that medica-
tion should not be routinely offered to children and young
people and that psychological treatment should be considered
the ﬁrst-line treatment. Although NICE is yet to report on the
non-social forms of anxiety disorders in childhood and adoles-
cence, there is nothing in the literature to suggest that their con-
clusion will be different concerning the use of anxiolytic
medication in these other forms of anxiety disorder.
FUTURE DIRECTIONS FOR CLINICAL RESEARCH
There is now convincing evidence that with good psychological
treatment the majority of children and young people with
anxiety disorders will show favourable outcomes. Little is
known, however, about why treatment is sometimes ineffective.
Recently several independent predictors of treatment outcome
from CBT have been identiﬁed: gender, primary anxiety sever-
ity, comorbid mood and externalising disorder, and the genetic
factors 5HTTLPR, NGF rs6330.53 The clinical utility of these
predictors remains to be determined. Notably, studies to date
have been limited in terms of consideration of ethnicity and
culture, and the extent to which treatment applies across cul-
tures remains to be established. Further, the extent to which
treatments apply to those with comorbid conditions is also yet
to be ﬁrmly established. James et al36 identiﬁed six studies of
the treatment of anxiety disorder among children and young
people with autistic spectrum disorders and found signiﬁcant
reductions in anxiety diagnoses compared to a waitlist control
condition. The interventions were typically modiﬁed to include
more applied behavioural analysis and greater repetition of
material over more sessions. These studies are encouraging in
demonstrating that, with appropriate adaptation, existing treat-
ments can be effectively applied to broader populations that
those typically included in treatment trials. Finally, further
research is required to determine whether children and young
people who do not respond to CBT may beneﬁt from subse-
quent pharmacotherapy, in the short and long term.
SUMMARY AND CONCLUSIONS
Anxiety disorders in childhood and adolescence are common,
often stable and present a risk for lifelong psychiatric disturb-
ance. It is a cause for concern that, despite the existence of
evidence-based interventions, the majority of children and
young people with anxiety disorders do not access treatment.
Numerous trials have now supported the effectiveness of CBT
for childhood anxiety disorders, compared to a waitlist condi-
tion. In recent years, a number of promising low-intensity
CBT-based treatments have been developed and evaluated that
offer a mechanism for increasing access to evidence-based treat-
ment for children and young people with anxiety disorders.
While there is some evidence for the effectiveness of SSRI
medication, this is to be weighed up against the potential risk of
harm in this age group, and the fact that so many questions con-
cerning administration remain unanswered. In view of these
concerns, recent guidelines state that pharmacological treat-
ments should not be offered routinely to children and young
people.
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